Last Price$37.29.3%
Market Cap$3,309.7M
$520.2M
+123.0% YoY
($348.1M)
-31.6% YoY
($865.8M)
Net Debt to FCF - 4.2x
($208.2M)
(40.0% margin)
LEGN Income Statement
LEGN Income Statement Overview
Crunching data... Almost there!
LEGN Income statement key metrics
Annual
Quarterly
LTM
LEGN Balance Sheet
LEGN Balance Sheet Overview
Annual
Quarterly
LTM
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Assets
Liabilities
Total assets
$1,848.6M
Current assets ($1,497.8M, 81.0% of total)
$1,308.7M (70.8%)
$157.1M (8.5%)
Other current assets
$32.0M (1.7%)
Non-current assets ($350.8M, 19.0% of total)
$4,362.0K (0.2%)
$189.7M (10.3%)
$4,061.0K (0.2%)
Other non-current assets
$152.7M (8.3%)
Financial position
($980.0M)
Cash & Short-term
Investments
Total Debt
LEGN Balance Sheet Metrics
Annual
Quarterly
LTM
LEGN Cash Flow Statement
LEGN Cash Flow Statement Overview
Annual
Quarterly
LTM
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
$491.7M Net Change in Cash
LEGN Cash Flow Statement key metrics
Annual
Quarterly
LTM
Operating Cash Flow (OCF)
($393.3M) +94.2% YoY
Capital Expenditure (CAPEX)
($22.7M) +104.4% YoY
Free Cash Flow (FCF)
($416.0M) +95.2% YoY
LEGN Financials
USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
| Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|
% growth | 23.6 0.0% | 49.1 108.2% | 57.3 16.5% | 75.7 32.2% | 89.8 18.7% | 117.0 30.3% | 285.1 143.7% |
| Cost of Goods Sold (COGS) | (0.1) | 0.0 | 0.0 | 232.2 | 313.3 | 65.4 | 144.2 |
% margin | 23.7 100.4% | 49.1 100.0% | 57.3 100.0% | (156.5) (206.8%) | (223.6) (249.0%) | 51.6 44.1% | 140.9 49.4% |
| Operating Expenses | 9.6 | 64.2 | 192.6 | 304.9 | 462.8 | 509.7 | 140.9 |
| Research & Development Expenses (R&D) | 8.2 | 60.6 | 161.9 | 232.2 | 313.3 | 335.6 | 382.2 |
| Selling, General & Administrative Expenses (SG&A) | 1.4 | 3.9 | 32.4 | 72.7 | 149.5 | 174.0 | 200.9 |
% margin | 13.8 58.4% | (1.5) (3.1%) | (130.9) (228.5%) | (313.3) (414.1%) | (393.0) (437.7%) | (455.8) (389.6%) | (439.5) (154.1%) |
| Interest Income | 0.0 | 6.2 | 4.6 | 2.9 | 1.0 | 8.2 | 54.5 |
| Interest Expense | 0.0 | 0.1 | 0.2 | 4.2 | 0.9 | 10.8 | 21.8 |
| Pre-tax Income | 13.8 | (1.6) | (130.4) | (307.6) | (386.2) | (445.7) | (520.1) |
% effective tax rate | 4.5 32.3% | 1.2 (72.3%) | 2.6 (2.0%) | (4.1) 1.3% | 0.0 (0.0%) | 0.6 (0.1%) | (1.9) 0.4% |
% margin | 9.4 39.7% | (2.8) (5.7%) | (133.0) (232.2%) | (303.5) (401.0%) | (386.2) (430.1%) | (446.3) (381.5%) | (518.3) (181.8%) |
| EPS | 0.07 | (0.03) | (1.01) | (2.57) | (2.74) | (2.81) | (2.94) |
| Diluted EPS | 0.07 | (0.03) | (1.01) | (2.57) | (2.74) | (2.81) | (2.94) |
% margin | 14.1 59.6% | 0.1 0.3% | (124.9) (218.1%) | (294.1) (388.7%) | (392.4) (437.0%) | (416.5) (356.0%) | (477.9) (167.6%) |
FAQ
What is the Legend Biotech Corporation (LEGN) revenue?
The Legend Biotech Corporation (LEGN) revenue is $285.1M, reflecting a year-over-year (YoY) growth of +143.7% YoY.
What is the Legend Biotech Corporation (LEGN) Net Income?
The Legend Biotech Corporation (LEGN) Net Income is ($518.3M), showcasing a YoY growth of +16.1% YoY.
What is Legend Biotech Corporation (LEGN) net debt?
What is the Legend Biotech Corporation (LEGN) Free Cash Flow (FCF)?
The Legend Biotech Corporation (LEGN) Free Cash Flow (FCF) stands at ($416.0M), accounting for a (145.9%) margin.